Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab Maintenance After Chemoradiation in LS-SCLC
NCT00193375Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Aug 2003
- Primary completion
- Apr 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in small cell lung cancer (SCLC), sponsored by SCRI Development Innovations. Started Aug 2003; status: completed.
02
Drugs
bevacizumab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00193375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193375.